Clinical Trial: DILIPO (DILutIonal HyPOnatremia)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

---

Official Title: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of a Vasopressin V2 Receptor Antagonist (SR121463B) on Serum Sodium in Patients Wit

Brief Summary:

Primary:

• To assess the efficacy of SR121463B in correcting hyponatremia in patients with dilutional hyponatremia other than SIADH or cirrhosis

Secondary:

• To assess the long-term efficacy of SR121463B in maintaining normonatremia in these patients
• To assess the safety and tolerability of SR121463B